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Abstract 
Introduction: Little is known about ethnic and gender disparities for transcatheter aortic valve 
replacement (TAVR) procedures in the United States. 
Methods: We queried the Nationwide Inpatient Sample (NIS) database (2011–2014) to identify patients 
who underwent TAVR. We described the temporal trends in the uptake of TAVR procedures among 
various ethnicities and genders. 
Results: Our analysis identified 39,253 records; 20,497 (52.2%) were men and 18,756 (47.8%) were 
women. Among all TAVRs, 87.2% were Caucasians, 3.9% were African Americans (AA), 3.7% were 
Hispanics, and 5.2% were of other ethnicities. We found a significant rise in the trend of TAVRs in all 
groups: in Caucasian men (coefficient = 0.946, p < 0.001), Caucasian women (coefficient = 0.985, p < 
0.001), AA men (coefficient = 0.940, p < 0.001), AA women (coefficient = 0.864, p < 0.001), Hispanic men 
(coefficient = 0.812, p = 0.001), Hispanic women (coefficient = 0.845, p < 0.001). Hence, the uptrend was 
most significant among Caucasian women, and relatively least significant among Hispanic men. 
Multivariate regression analysis was conducted to evaluate in-hospital mortality among different groups 
after adjusting for demographics and baseline characteristics. After multivariable regression for baseline 
characteristics overall, the in-hospital mortality per 100 TAVRs was highest among Hispanic men 5.5%, 
followed by Caucasian women 5.0%, Hispanic women 4.6%, AA women 3.7%, AA men 3.4%, and 
Caucasian men 3.38% (adjusted p value = 0.004). 
Conclusions: In this observational study, we demonstrated that there is evidence of ethnic and gender 
differences in the overall uptake and adjusted mortality of TAVRs in the United States. 
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ABSTRACT
Introduction: Little is known about ethnic and
gender disparities for transcatheter aortic valve
replacement (TAVR) procedures in the United
States.
Methods: We queried the Nationwide Inpatient
Sample (NIS) database (2011–2014) to identify
patients who underwent TAVR. We described
the temporal trends in the uptake of TAVR pro-
cedures among various ethnicities and genders.
Results: Our analysis identified 39,253 records;
20,497 (52.2%) were men and 18,756 (47.8%)
were women. Among all TAVRs, 87.2% were
Caucasians, 3.9% were African Americans (AA),
3.7% were Hispanics, and 5.2% were of other
ethnicities. We found a significant rise in the
trend of TAVRs in all groups: in Caucasian men
(coefficient = 0.946, p\ 0.001), Caucasian
women (coefficient = 0.985, p\ 0.001), AA
men (coefficient = 0.940, p\ 0.001), AA
women (coefficient = 0.864, p\ 0.001), His-
panic men (coefficient = 0.812, p = 0.001), His-
panic women (coefficient = 0.845, p\0.001).
Hence, the uptrend was most significant among
Caucasian women, and relatively least signifi-
cant among Hispanic men. Multivariate regres-
sion analysis was conducted to evaluate in-
hospital mortality among different groups after
adjusting for demographics and baseline char-
acteristics. After multivariable regression for
baseline characteristics overall, the in-hospital
mortality per 100 TAVRs was highest among
Hispanic men 5.5%, followed by Caucasian
women 5.0%, Hispanic women 4.6%, AA
women 3.7%, AA men 3.4%, and Caucasian
men 3.38% (adjusted p value = 0.004).
Conclusions: In this observational study, we
demonstrated that there is evidence of ethnic
and gender differences in the overall uptake and
adjusted mortality of TAVRs in the
United States.
Keywords: Gender disparities; Racial
disparities; Transcatheter aortic valve
replacement
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Transcatheter aortic valve replacement (TAVR)
emerged as alternative to surgical replacement
for patients with severe aortic stenosis [1–3].
However, little is known about ethnic and
gender disparities for TAVR procedures in the
United States. This study aimed to evaluate the
temporal changes in the uptake of TAVR pro-
cedures among the major ethnic groups.
Using the Nationwide Inpatient Sample
(NIS) database years 2011–2014, we identified
patients who underwent TAVR procedures
using International Classification of Diseases
procedure code-9; (trans-femoral 35.05 and
trans-apical 35.06). Using linear logistic regres-
sion analysis, we described the temporal trends
in number of TAVR procedures and mortality
among various ethnicities and genders. Effect
sizes were expressed using co-efficient of
regression. Multivariable regression analysis was
conducted to compare in-hospital mortality
among different study groups. The model
included the following variables: age, hyper-
tension, diabetes mellitus, congestive heart
failure, chronic lung disease, chronic kidney
disease (CKD), obesity, anemia, hypothy-
roidism, liver disease, fluid/electrolytes abnor-
malities, peripheral vascular disease, pulmonary
circulation disorders, smokers, history of PCI,
history of coronary artery bypass grafting, prior
MI, and access route for TAVR.
From 2011 to 2014, 42,189 records under-
went TAVR. After excluding records with miss-
ing data regarding ethnicity (2936), the final
cohort included 39,253 records; 20,497 (52.2%)
were men and 18,756 (47.8%) were women.
Among all TAVRs, 34,229 (87.2%) were Cau-
casians, 1527 (3.9%) were African Americans
(AA), 1471 (3.7%) were Hispanics and 2027
(5.2%) were of other ethnicities. Among Cau-
casians, 18,023 (52.7%) were men and 16,206
(47.3%) were women, among AA ethnicity 589
(38.6%) were men and 937 (61.4%) were
women, while among Hispanics 825 (56.1%)
were men and 646 (43.9%) were women. Base-
line characteristics for different study groups are
outlined in Table 1.
From 2011 to 2014, there was an increase in
TAVRs in Caucasian men from 493 in the 2011
quarter (q)4 to 2470 in 2014-q4 with a signifi-
cant change of trend (coefficient = 0.946,
p\0.001), and in Caucasian women from 381
in 2011-q4 to 2280 in 2014-q4 (coeffi-
cient = 0.985, p\ 0.001). Among AA men,
TAVRs increased from 11 in 2011-q4 to 85 in
2014-q4 (coefficient = 0.940, p\0.001), and in
AA women TAVRs increased from 37 in 2011-q4
to 140 in 2014-q4 (coefficient = 0.864,
p\0.001). In Hispanic men, there was an
increase in TAVRs from 11 in 2011-q4 to 100 in
2014-q4 (coefficient = 0.812, p = 0.001), while
in Hispanic women, TAVRs increased from 11 in
2011-q4 to 90 in 2014-q4 (coefficient = 0.845,
p\0.001) (Fig. 1). Hence, the uptrend was most
significant among Caucasian women, and rela-
tively least significant among Hispanic men.
Multivariate regression analysis was con-
ducted to evaluate in-hospital mortality among
different groups after adjusting for demograph-
ics and baseline characteristics. Overall, the in-
hospital mortality per 100 TAVRs was highest
among Hispanic men 5.5% (45/825), followed
by Caucasian women 5.0% (804/15,402), His-
panic women 4.6% (30/646), AA women 3.7%
(35/937), AA men 3.40% (20/589), and Cau-
casian men 3.38% (610/18,023) (adjusted
p value = 0.004). Temporal changes in the in-
hospital mortality among different groups are
outlined in Fig. 1. Overall, there was no signifi-
cant change in the trends, despite some
numerical differences along the years.
In this observational study, we demonstrated
that there is evidence of ethnic and gender
differences in the overall uptake of TAVRs in the
US. According to the United States Census
Bureau, AA and Hispanics represent 13% and
17.1% of the general population, respectively
[5]. However, in our study, they only repre-
sented 3.9% and 3.7% of the TAVR procedures,
respectively. We have demonstrated a signifi-
cant uptrend in the number of TAVRs in all
groups, which was most significant in Cau-
casian women, and least in Hispanic men. Data
from the Society of Thoracic Surgeons/Ameri-
can College of Cardiology Transcatheter Valve
Therapy (TVT) have reported ethnic differences
in the uptake of TAVRs in the United States [4].
In their report including 26,378 TAVRs from
2012 to 2014, the majority were Caucasians
(93.8%) and AA represented only 3.8% of all
TAVRs [4]. The present study extends our
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knowledge by examining other ethnicities and
evaluating gender differences as well. Further,
we demonstrated ethnic and gender disparities
in the adjusted in-hospital mortality rate, which
was highest among Hispanic men followed by
Caucasian women.
The background for ethnic disparities in the
uptake of TAVR is multi-factorial. Socio-eco-
nomic status and insurance coverage play
important roles in preventing certain groups
from receiving TAVRs. Reports from the United
States Census Bureau suggested higher rates of
non-insurance among minorities; reaching
10.5% in AA and 16% among Hispanics com-
pared with 6.3% among Caucasians [5]. Cultural
differences may also play a role, with reports of
higher propensities to refuse invasive treat-
ments among some minorities compared to
Caucasians [6]. Importantly, minorities have
been underrepresented in major clinical trials
and specifically for TAVR [1].
This analysis is limited by the data source,
which is an administrative database, and liable
to documentation errors. Also, the NIS provides
only data related to the index hospitalization,
with no available long-term data. Being an
Table 1 Baseline characteristics among different study groups
Characteristics White
females
(n = 16,206)
White males
(n = 18,023)
AA
females
(n = 937)
AA males
(n = 589)
Hispanic
females
(n = 646)
Hispanic
males
(n = 809)
P value
N % N % N % N % N % N %
Hypertension 13,006 80.3 14,195 78.8 788 84.0 474 80.5 526 81.4 679 82.3 \ 0.001
Diabetes mellitus 5088 31.4 6354 35.3 424 45.3 240 40.7 295 45.7 384 46.6 \ 0.001
Heart failure 2015 12.4 2014 11.2 140 14.9 80 13.6 75 11.6 90 10.9 \ 0.001
Chronic lung disease 5300 32.7 6298 34.9 269 28.7 184 31.2 196 30.3 259 31.4 \ 0.001
CKD 4595 28.4 7248 40.2 390 41.6 375 63.6 196 30.3 400 48.5 \ 0.001
Obesity 2594 16.0 2046 11.4 240 25.6 80 13.6 120 18.6 75 9.1 \ 0.001
Chronic anemia 4436 27.4 4325 24.0 343 36.6 230 39.0 201 31.1 250 30.3 \ 0.001
Coagulopathy 3454 21.3 4539 25.2 249 26.6 170 28.9 160 24.8 290 35.2 \ 0.001
Hypothyroidism 4594 28.3 2514 13.9 165 17.6 50 8.5 155 24.0 105 12.7 \ 0.001
Chronic liver disease 373 2.3 462 2.6 20 2.1 30 5.1 15 2.3 31 3.8 \ 0.001
Fluid and electrolyte disorders 4492 27.7 4297 23.8 333 35.5 165 28.0 196 30.3 210 25.5 \ 0.001
Pulmonary circulation
disorders
680 4.2 600 3.3 25 2.7 45 7.6 30 4.6 25 3.0 \ 0.001
Tobacco use 3268 20.2 6369 35.3 160 17.1 195 33.1 105 16.3 239 29.0 \ 0.001
History of PCI 2638 16.3 3839 21.3 95 10.1 95 16.1 90 13.9 164 19.9 \ 0.001
History of CABG 2033 12.5 5822 32.3 55 5.9 65 11.0 70 10.8 245 29.7 \ 0.001
Prior myocardial infarction 1591 9.8 2900 16.1 80 8.5 80 13.6 60 9.3 85 10.3 \ 0.001
Trans-femoral TAVR 12,601 77.8 14,933 82.9 803 85.6 505 85.6 476 73.6 571 69.2 \ 0.001
Trans-apical TAVR 3630 22.4 3139 17.4 135 14.4 85 14.4 171 26.4 254 30.8 \ 0.001
CKD chronic kidney disease, AA African American, PCI percutaneous coronary intervention, CABG coronary artery bypass
grafting
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observation study, there is always potential for
selection bias. However, we attempted to reduce
allocation bias by conducting multivariable
regression analyses. Useful information, such as
medications, laboratory data, as well as type of
TAVR valves, was unavailable through this
database. Further studies are encouraged to
identify barriers for uptake of TAVR by minori-
ties, as well as to better specify ethnic and
gender differences in outcomes of TAVR
procedures.
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